105 related articles for article (PubMed ID: 1780749)
1. Effects of treatment regimens on post marrow transplant relapse.
Buckner CD; Clift RA; Appelbaum FR; Storb R; Fefer A; Petersen FB; Sanders JE; Sullivan K; Thomas ED; Hansen JA
Semin Hematol; 1991 Jul; 28(3 Suppl 4):32-4. PubMed ID: 1780749
[No Abstract] [Full Text] [Related]
2. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
[TBL] [Abstract][Full Text] [Related]
3. Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Buckner CD; Clift RA; Appelbaum FR; Storb R; Petersen FB; Sanders JE; Thomas ED; Hansen JA
Bone Marrow Transplant; 1991; 7 Suppl 2():6-8. PubMed ID: 1878723
[No Abstract] [Full Text] [Related]
4. The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.
Frassoni F; Bacigalupo A; Sessarego M; Gualandi F; Lamparelli T; Van Lint MT; Occhini D; Corvò R; Scarpati D; Vitale V
Bone Marrow Transplant; 1991; 7 Suppl 2():130. PubMed ID: 1878675
[No Abstract] [Full Text] [Related]
5. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
6. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
Labar B; Bogdanić V; Nemet D; Mrsić M; Vrtar M; Grgić-Markulin L; Kalenić S; Vujasinović S; Presecki V; Jakić-Razumović J
Bone Marrow Transplant; 1992 May; 9(5):343-7. PubMed ID: 1617318
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
8. Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary).
Poros A; Petrányi J; Harsányi V; Mód A; Bernyäk J; Hollán Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):409-11. PubMed ID: 2480282
[No Abstract] [Full Text] [Related]
9. Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse.
Scarpati D; Frassoni F; Vitale V; Corvo R; Franzone P; Barra S; Guenzi M; Orsatti M
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):547-52. PubMed ID: 2674077
[TBL] [Abstract][Full Text] [Related]
10. Total body irradiation dose and relapse risk after marrow transplantation for leukemia.
Frassoni F; Bacigalupo A; Marmont A; Scarpati D; Corvò R; Vitale V
Blood; 1991 Jun; 77(11):2543-4. PubMed ID: 2039837
[No Abstract] [Full Text] [Related]
11. [Allogeneic bone marrow transplantation in the treatment of leukemia: analysis of 10 cases].
Cao LX; Zeng TQ; Chen H
Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):415-7, 456. PubMed ID: 1684316
[TBL] [Abstract][Full Text] [Related]
12. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s.
Bortin MM; Horowitz MM; Gale RP; Barrett AJ; Champlin RE; Dicke KA; Gluckman E; Kolb HJ; Marmont AM; Mrsic M
JAMA; 1992 Aug; 268(5):607-12. PubMed ID: 1321298
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for the treatment of leukaemia-results of the Munich Cooperative Group.
Kolb HJ; Bender-Götze C; Haas RJ; Holler E; Thierfelder S; Wilmanns W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):397-402. PubMed ID: 2480280
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelocytic leukemia: development of conditioning regimens for marrow transplantation.
Storb R
Leukemia; 1993 Aug; 7 Suppl 2():S135-7. PubMed ID: 8361218
[No Abstract] [Full Text] [Related]
15. Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT.
Hiraoka A; Shibata H; Masaoka T
Transplant Proc; 1992 Dec; 24(6):3047-8. PubMed ID: 1466051
[No Abstract] [Full Text] [Related]
16. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
17. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.
Kolb HJ; Mittermüller J; Clemm C; Holler E; Ledderose G; Brehm G; Heim M; Wilmanns W
Blood; 1990 Dec; 76(12):2462-5. PubMed ID: 2265242
[TBL] [Abstract][Full Text] [Related]
18. Chronic myeloid leukemia treated by allogeneic bone marrow transplantation.
Szer J; Sheridan WP
Transplant Proc; 1992 Feb; 24(1):181-2. PubMed ID: 1539235
[No Abstract] [Full Text] [Related]
19. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks.
Igaki H; Karasawa K; Sakamaki H; Saito H; Nakagawa K; Ohtomo K; Tanaka Y
Strahlenther Onkol; 2005 Nov; 181(11):704-8. PubMed ID: 16254705
[TBL] [Abstract][Full Text] [Related]
20. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
